Narasin, a Novel Antiviral Compound that Blocks Dengue Virus Protein Expression

Abstract

Narasin was identified and characterized as a novel agent that inhibits DENV replication in vitro through non-cytotoxic mechanisms, thus indicating its potential to be further developed as a therapeutic anti-DENV agent.